- Messages
- 7,141
- Type of diabetes
- Treatment type
- Diet only
I read about this new wonder drug for T2D on our diabetes.co.uk website.
When we have LCHF and metformin if we need a bit more help if LCHF isn't enough to bring down BS - why oh why would Novo Nordisk think anybody would want to risk all the issues that this drug could cause:
The first glucagon-like peptide-1 (GLP-1) receptor agonist in tablet form has been approved for people with type 2 diabetes in the US.
Rybelsus, (medication name semaglutide) has been approved by the US's official drugs body the Food and Drug Administration (FDA).
Rybelsus will carry a 'boxed warning' that there is a potential increased risk of thyroid c-cell tumors. Additional warnings regarding the drug relate to pancreatitis, diabetic retinopathy, hypoglycemia, acute kidney injury and hypersensitivity reactions.
Novo Nordisk executive vice-president and chief science officer Mads Krogsgaard Thomsen said: "We are very excited that we can make the first oral GLP-1 available in the US and thereby expand the treatment options for adults living with type 2 diabetes.
Sorry for the rant - reading about this drug made me feel quite angry.
When we have LCHF and metformin if we need a bit more help if LCHF isn't enough to bring down BS - why oh why would Novo Nordisk think anybody would want to risk all the issues that this drug could cause:
The first glucagon-like peptide-1 (GLP-1) receptor agonist in tablet form has been approved for people with type 2 diabetes in the US.
Rybelsus, (medication name semaglutide) has been approved by the US's official drugs body the Food and Drug Administration (FDA).
Rybelsus will carry a 'boxed warning' that there is a potential increased risk of thyroid c-cell tumors. Additional warnings regarding the drug relate to pancreatitis, diabetic retinopathy, hypoglycemia, acute kidney injury and hypersensitivity reactions.
Novo Nordisk executive vice-president and chief science officer Mads Krogsgaard Thomsen said: "We are very excited that we can make the first oral GLP-1 available in the US and thereby expand the treatment options for adults living with type 2 diabetes.
Sorry for the rant - reading about this drug made me feel quite angry.